JPS63104929A - 遺伝子組換えヒトα−インターフェロンによるエイズウイルス血症患者の治療法 - Google Patents

遺伝子組換えヒトα−インターフェロンによるエイズウイルス血症患者の治療法

Info

Publication number
JPS63104929A
JPS63104929A JP62267607A JP26760787A JPS63104929A JP S63104929 A JPS63104929 A JP S63104929A JP 62267607 A JP62267607 A JP 62267607A JP 26760787 A JP26760787 A JP 26760787A JP S63104929 A JPS63104929 A JP S63104929A
Authority
JP
Japan
Prior art keywords
interferon
htlv
recombinant human
million
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62267607A
Other languages
English (en)
Japanese (ja)
Inventor
ジュディス・フェインバーグ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering Plough Corp
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25446188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS63104929(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Publication of JPS63104929A publication Critical patent/JPS63104929A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP62267607A 1986-10-22 1987-10-22 遺伝子組換えヒトα−インターフェロンによるエイズウイルス血症患者の治療法 Pending JPS63104929A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92192286A 1986-10-22 1986-10-22
US921922 1986-10-22

Publications (1)

Publication Number Publication Date
JPS63104929A true JPS63104929A (ja) 1988-05-10

Family

ID=25446188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62267607A Pending JPS63104929A (ja) 1986-10-22 1987-10-22 遺伝子組換えヒトα−インターフェロンによるエイズウイルス血症患者の治療法

Country Status (8)

Country Link
EP (1) EP0266940B1 (enExample)
JP (1) JPS63104929A (enExample)
AT (1) ATE83381T1 (enExample)
CA (1) CA1297788C (enExample)
DE (1) DE3783122T2 (enExample)
ES (1) ES2052579T3 (enExample)
GR (1) GR3006999T3 (enExample)
OA (1) OA08768A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022542106A (ja) * 2019-07-22 2022-09-29 シャーメン アモイトップ バイオテック カンパニー， リミテッド インターフェロンベースの疾患治療法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011025A2 (en) * 1990-12-21 1992-07-09 Schering Corporation Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
MX9307733A (es) * 1992-12-23 1994-06-30 Schering Corp Restauracion de la funcion inmunologica en pacientes asintomaticos de vih-positivo.
FR2713657B1 (fr) * 1993-12-13 1996-03-01 Transgene Sa Nouveaux vecteurs pour le traitement du sida.
WO2009134750A1 (en) 2008-04-28 2009-11-05 Janssen Pharmaceutica Nv Benzoimidazoles as prolyl hydroxylase inhibitors
HUE052128T2 (hu) 2011-10-25 2021-04-28 Janssen Pharmaceutica Nv Eljárás az 1-(5,6-diklór-1H-benzo[d]imidazol-2-il)-1H-pirazol-4-karbonsav meglumin sója kristályainak elõállítására

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF INTERFERON RESEARCH=1986 *
THE JOURNAL OF INFECTIOUS DISEASES=1986 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022542106A (ja) * 2019-07-22 2022-09-29 シャーメン アモイトップ バイオテック カンパニー， リミテッド インターフェロンベースの疾患治療法

Also Published As

Publication number Publication date
DE3783122T2 (de) 1993-04-22
ATE83381T1 (de) 1993-01-15
ES2052579T3 (es) 1994-07-16
GR3006999T3 (enExample) 1993-06-30
DE3783122D1 (de) 1993-01-28
CA1297788C (en) 1992-03-24
OA08768A (fr) 1989-03-31
EP0266940A1 (en) 1988-05-11
EP0266940B1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
Lane et al. Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma
Gelmann et al. Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS
Nair et al. Immunoregulatory effects of morphine on human lymphocytes
Davis et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection
Goncalves et al. Role of Vif in human immunodeficiency virus type 1 reverse transcription
Pitha Multiple effects of interferon on the replication of human immunodeficiency virus type 1
Shaw et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy
Fultz et al. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome
Hall et al. Multiple isolates and characteristics of human T-cell leukemia virus type II
MANO et al. Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester
Kestelyn et al. HIV and conjunctival malignancies
Marthas et al. Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus
Delgado et al. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
Fauci Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome.
Nara et al. The biology of human immunodeficiency virus‐1 IIIB infection in the chimpanzee: in vivo and in vitro correlations
Koyanagi et al. Establishment of a high production system for AIDS retroviruses with a human T-leukemic cell line Molt-4
Frumkin et al. Acute infection of Macaca nemestrina by human immunodeficiency virus type 1
Wong-Staal et al. Retrovirus sequences in a leukemic gibbon and its contact: evidence for partial provirus in the nonleukemic gibbon.
Barré-Sinoussi et al. Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS
JPS63104929A (ja) 遺伝子組換えヒトα−インターフェロンによるエイズウイルス血症患者の治療法
NAGASHUNMUGAM et al. Human submandibular saliva specifically inhibits HIV type 1
Bosch et al. Infection ofMacaca nemestrinaneonates with HIV-1 via different routes of inoculation
Boadi et al. Cellulose acetate 1, 2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus
McMinn et al. Antigenic drift of influenza A (H3N2) virus in a persistently infected immunocompromised host is similar to that occurring in the community
Paterlini et al. Polymerase chain reaction for studies of mother to child transmission of HIV1 in Africa